Routes of
administration Oral CAS Number 137975-06-5 IUPHAR/BPS 2197 | ATC code none PubChem CID 119369 | |
 | ||
Legal status In general: ℞ (Prescription only) | ||
How to pronounce mozavaptan
Mozavaptan (INN) is a vasopressin receptor antagonist marketed by Otsuka. In Japan, it was approved in October 2006 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH) due to ADH producing tumors.
References
Mozavaptan Wikipedia(Text) CC BY-SA